Jesús Arribas
Chief Financial Officer
Jesús Arribas is a Chief Financial Officer with a distinguished track record in managing and optimizing finance departments. He has played a crucial role in the development of annual budgets, monthly updates, and long-term strategic plans. His experience includes preparing detailed financial reports, overseeing cash flow, projecting treasury positions, and managing relationships with financial institutions. He manages both JSC finances and provides consulting support to JSC’s clients on Market Access and financial matters.
Additionally, Jesús has worked as Management consultant, advising various companies on optimizing accounting processes, financial projections, and audits. His focus on improving profitability and managing risks has been essential in minimizing financial exposure and maximizing business performance.
Throughout his career, Jesús has demonstrated an exceptional ability to prepare and present financial reports to investors, ensuring smooth communication and proactively addressing their concerns and requirements. His expertise in reviewing financial margins and overseeing the control of commercial, financial, and legal risks has been crucial to the success of the organizations he has collaborated with.
Jesús Arribas combines his deep technical knowledge in finance with strategic vision, bringing significant value to every project he leads. His commitment to excellence and financial accuracy has been recognized throughout his career, making him an invaluable asset to any company.
Meet selected experts within our global team
We mobilize project teams of 50+ market access consultancy specialists
Justin Stindt
Founder and Managing Director
Justin is an experienced Market Access strategist with a background at GlaxoSmithKline and in consulting. Justin supports pharma, biotech and medtech clients with Market Access strategy and execution. He has led hundreds of Pricing & Reimbursement projects, overseen development of Pricing & Reimbursement dossiers, led engagements with HTA bodies and conducted price negotiations on behalf of clients. Justin is fluent in English, French, German, and Spanish.
Javier Arribas Díaz
Partner
With a focus on orphan drugs, Javier is experienced in advising pharmaceutical and medtech clients on market access and pricing strategies. Javier is both leading global projects and activities focused on the Spanish market such as the development of Spanish Pricing & Reimbursement strategies and dossiers. Javier has prior consulting experience at Accenture and Werfen. He studied at Kellogg School of Management in the US, did an MBA at IESE in Spain, and is proficient in Spanish and English.
Anne Stindt
Director
Anne is a health insurance specialist with a background in digital marketing and health and medical insurance purchasing at AXA where she held roles both on corporate level in the headquarter in Paris and on affiliate level in Germany. At Justin Stindt Consultants, she leads global research projects and develops Pricing & Reimbursement strategies. She is fluent in French, English, German and Portuguese and holds a Master’s degree from ESCP-EAP Business School.
Jesús Arribas
Chief Financial Officer
Jesús Arribas is a finance expert with extensive experience as a Chief Financial Officer and Management Consultant. He has led the creation and optimization of finance departments, developed long-term strategies, and improved accounting processes. His ability to advise on financial projections and audits has been key to the success of multiple companies.
Eva Brčić
Senior Consultant
Eva specializes in strategic market access research for pharmaceutical and biotech firms. Her projects include pricing and reimbursement analysis, research in medical information and Pricing & Reimbursement databases, and expert interviews with payers and clinical experts. Eva is fluent in English, French, and Croatian and has a Master in Management and a Bachelor’s in Psychology from the Erasmus University Rotterdam.
Joaquim Knox
Senior Consultant
Joaquim Knox is a senior consultant with a strong foundation in biochemistry with experience in drug development and business development in the pharmaceutical industry. Holding a Bachelor’s degree in Biological Sciences, with emphasis in Biochemistry, from UNIRIO, and a Masters degree in Pharma and Biotech Management from EADA Business School, Joaquim focuses on developing strategic Pricing and Reimbursement strategies for pharmaceutical and biotech companies. With a background spanning from preclinical strategy to clinical development in different therapeutic fields, such as Urology, Ophthalmology, Respiratory and Orphan Drugs, Joaquim brings valuable insights into the intricacies of drug development. Additionally, his work in Business Development and Licensing roles across the pharma and biotech industry, enhances his ability to navigate complex market landscapes. Joaquim is proficient in Portuguese, English and Spanish.
Matteo Brunelli
Consultant
Matteo focuses on Market Access and Pricing & Reimbursement strategies for pharmaceutical and biotech companies. His work combines market access research with quantitative analysis, covering pricing and reimbursement landscapes, benchmarking, and payer and HTA environments across European markets. He holds a bachelor’s degree in Economics and Finance from Bocconi University and is currently completing a master’s degree in Accounting, Financial Management and Control. Matteo is a native Italian speaker and is fluent in English.
Matteo Proietti
Consultant
Matteo supports Market Access research for pharmaceutical and biotech companies, bringing a quantitative and business-oriented perspective through his background in finance, valuation, and data analysis. He holds a bachelor’s degree in Economics and Finance from Bocconi University and is currently completing a master’s degree in Accounting, Financial Management and Control. Matteo is a native Italian speaker and is fluent in English and French.
Charlotte Guillemot
Consultant
Charlotte specialises in Pricing and Reimbursement, and Market Access strategies for pharmaceutical and biotech companies. She supports projects focused on pricing, statutory rebates, and commercial agreements between manufacturers and payers across the EU-5. She holds a master’s degree in Biotech & Pharmaceutical Management from University College London (UCL) and is fluent in English and French.
Iliya Khanbani
Consultant
Iliya is a Consultant focusing on market access and Pricing & Reimbursement strategies for pharmaceutical and biotech companies. His project experience includes early access programmes, HTA assessments, indication prioritization, and strategic market research across the US and major European markets. He holds a bachelor’s degree in Mechanical Engineering and a Master in Management with a major in Economics and Finance from HEC Paris. He speaks English and French.
Nabil Abu Moamar
Consultant
Nabil has experience in strategy and commercial due diligence, including M&A due diligence, sell-side divestments, and international market entry projects. He holds a bachelor’s degree in Economics and Finance and a master’s degree in Accounting and Finance from Bocconi University, with international study experience in Oslo and Porto. He speaks Italian, English, and Spanish.
Miroslava Jurcova
Sales Operations Assistant & Executive Support to the CEO
Miroslava supports sales operations and provides executive support to the CEO, focusing on commercial coordination, CRM management, business development, and executive organisation. Her professional background spans marketing, client relations, and executive assistance, including experience in the pharmaceutical sector, where she supported marketing activities and senior management. She holds a degree from the Business Academy, with a focus on marketing and accounting, and is fluent in Slovak, Czech, French, and English.